CrushSCI.com
提供学术论文选刊润色服务
Clinical and Translational Allergy 期刊封面 医学
返回期刊列表

Review Cycle Records

Clinical and Translational Allergy

Wiley SCIE OA
2026新锐 2区2025中科院 2区2025 JCR Q2
107.1平均天数
113.5中位天数
13最短天数
205最长天数
1242025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

113 天

Chemokines during anaphylaxis: the importance of CCL2 and CCL2-dependent chemotactic activity for basophils

作者Romana Vantur; Marusa Rihar; Ana Koren; Matija Rijavec; Peter Kopac; Urska Bidovec-Stojkovic; Renato Erzen; Peter Korosec

作者单位1. University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia; 2. Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 3. Medical Faculty, University of Ljubljana, Ljubljana, Slovenia

PDF源文件 DOI 网页
114 天

Epigenome-wide association study identifies DNA methylation markers for asthma remission in whole blood and nasal epithelium

作者Cancan Qi; Judith M. Vonk; Diana A. van der Plaat; Maartje A. E. Nieuwenhuis; F. Nicole Dijk; Dylan Aïssi; Valérie Siroux; H. Marike Boezen; Cheng-jian Xu; Gerard H. Koppelman

作者单位1. Department of Pediatric Pulmonology and Pediatric Allergy, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 2. GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 4. University Grenoble Alpes, Inserm, CNRS, Team of environmental epidemiology applied to Reproduction and Respiratory health, IAB (Institute for Advanced Biosciences), Grenoble, France; 5. Research Group of Bioinformatics and Computational Genomics, CiiM, Centre for individualized infection medicine, A Joint Venture Between Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 6. Department of Gastroenterology, Hepatology and Endocrinology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture Between the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany; 7. Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands

PDF源文件 DOI 网页
158 天

A novel ELISA method to determine human MrgX2 in chronic urticaria

作者Yuanyuan Ding; Tao Zhang; Rui Liu; Delu Che; Nan Wang; Langchong He

作者单位1. College of Pharmacy, Xi’an Jiaotong University, Xi’an, China

PDF源文件 DOI 网页
177 天

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

作者A. Bédard; X. Basagaña; J. M. Anto; J. Garcia-Aymerich; P. Devillier; S. Arnavielhe; A. Bedbrook; G. L. Onorato; W. Czarlewski; R. Murray; R. Almeida; J. A. Fonseca; J. Correia da Sousa; E. Costa; M. Morais-Almeida; A. Todo-Bom; L. Cecchi; G. De Feo; M. Illario; E. Menditto; R. Monti; C. Stellato; M. T. Ventura; I. Annesi-Maesano; I. Bosse; J. F. Fontaine; N. Pham-Thi; M. Thibaudon; P. Schmid-Grendelmeier; F. Spertini; N. H. Chavannes; W. J. Fokkens; S. Reitsma; R. Dubakiene; R. Emuzyte; V. Kvedariene; A. Valiulis; P. Kuna; B. Samolinski; L. Klimek; R. Mösges; O. Pfaar; S. Shamai; R. E. Roller-Wirnsberger; P. V. Tomazic; D. Ryan; A. Sheikh; T. Haahtela; S. Toppila-Salmi; E. Valovirta; V. Cardona; J. Mullol; A. Valero; M. Makris; N. G. Papadopoulos; E. P. Prokopakis; F. Psarros; C. Bachert; P. W. Hellings; B. Pugin; C. Bindslev-Jensen; E. Eller; I. Kull; E. Melén; M. Wickman; G. De Vries; M. van Eerd; I. Agache; I. J. Ansotegui; S. Bosnic-Anticevich; A. A. Cruz; T. Casale; J. C. Ivancevich; D. E. Larenas-Linnemann; M. Sofiev; D. Wallace; S. Waserman; A. Yorgancioglu; D. Laune; J. Bousquet

作者单位1. ISGlobal, Barcelona, Spain; 2. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 3. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 4. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 5. UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France; 6. KYomed INNOV, Montpellier, France; 7. CHU de Montpellier, Montpellier, France; 8. Medical Consulting Czarlewski, Levallois, France; 9. Research fellow, OPC, and Director, Cambridge, UK; 10. Medscript, Paraparaumu, New Zealand; 11. Faculdade de Medicina da Universidade do Porto, Lda Porto, Portugal; 12. MEDIDA, Lda, Porto, Portugal; 13. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; 14. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal; 15. Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 16. UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal; 17. Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal; 18. Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal; 19. SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy; 20. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana, University of Salerno, Salerno, Italy; 21. Division for Health Innovation, Campania Region, Federico II University Hospital Naples (R&D and DISMET), Naples, Italy; 22. CIRFF, Federico II University, Naples, Italy; 23. Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino, Mauriziano Hospital, Turin, Italy; 24. Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy; 25. Medical School Saint Antoine, Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Université, Paris, France; 26. Allergist La Rochelle, La Rochelle, France; 27. Allergist, Reims, France; 28. Ecole Polytechnique Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées), Bretigny, France; 29. RNSA (Réseau National de Surveillance Aérobiologique), Brussieu, France; 30. Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 31. Service Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 32. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands; 33. Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands; 34. Clinic of Chest Diseases, Immunology and Allergology, Medical Faculty, Vilnius University, Vilnius, Lithuania; 35. Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; 36. Department of Pathology, Faculty of Medicine and Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Institute of Clinical Medicine, Vilnius, Lithuania; 37. Vilnius University Institute of Clinical Medicine, Clinic of Children’s Diseases, Department of Public Health, and Institute of Health Sciences, Vilnius, Lithuania; 38. European Academy of Paediatrics, EAP/UEMS-SP), Brussels, Belgium; 39. Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; 40. Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland; 41. Center for Rhinology and Allergology, Wiesbaden, Germany; 42. Medical Faculty, CRI-Clinical Research International-Ltd, Institute of Medical Statistics, and Computational Biology, University of Cologne, Hamburg, Germany; 43. Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany; 44. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 45. Department of ENT, Medical University of Graz, Graz, Austria; 46. Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK; 47. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 48. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 49. Department of Lung Diseases and Clinical Immunology, University of Turku, Terveystalo Allergy Clinic, Turku, Finland; 50. Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron, ARADyAL Research Network, Barcelona, Spain; 51. Rhinology Unit, & Smell Clinic, ENT Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; 52. Pneumology and Allergy Department CIBERES and Clinical, & Experimental Respiratory Immunoallergy, IDIBAPS, University of Barcelona, Barcelona, Spain; 53. Allergy Unit “D Kalogeromitros”, 2nd Dpt of Dermatology and Venereology, National & Kapodistrian University of Athens, “Attikon” University Hospital, Athens, Greece; 54. Division of Infection, & Respiratory Medicine, Royal Manchester Children’s Hospital Immunity, University of Manchester, Manchester, UK; 55. Allergy Department, 2nd Pediatric Clinic, Athens General Children’s Hospital “P&A Kyriakou,” University of Athens, Athens, Greece; 56. Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece; 57. Allergy Department, Athens Naval Hospital, Athens, Greece; 58. Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, Ghent, Belgium; 59. Sun Yat-sen University, International Airway Research Center, Guangzou, China; 60. Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden; 61. Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden; 62. Academic Medical Center, Univ of Amsterdam, Dept of Otorhinolaryngology, Univ Hospitals Leuven, Leuven, The Netherlands; 63. European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium; 64. Odense University Hospital, Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark; 65. Thermofisher Scientific, Uppsala, Sweden; 66. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sach´s Children and Youth Hospital, Södersjukhuset, Sweden; 67. Sachs’ Children and Youth Hospital, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 68. Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden; 69. Peercode BV, Geldermalsen, The Netherlands; 70. Transylvania University Brasov, Brasov, Romania; 71. Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain; 72. Woolcock Institute of Medical Research, University of Sydney, Woolcock Emphysema Centre, Sydney Local Health District, Glebe, Australia; 73. Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil; 74. WHO GARD Planning Group, Salvador, Brazil; 75. Division of Allergy/Immunology, University of South Florida, Tampa, USA; 76. Clinica Santa Isabel, Servicio de Alergia e Immunologia, Buenos Aires, Argentina; 77. Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico; 78. Finnish Meteorological Institute (FMI), Helsinki, Finland; 79. Nova Southeastern University, Fort Lauderdale, USA; 80. Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Canada; 81. Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey; 82. University Hospital, Montpellier, France; 83. INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France; 84. Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France; 85. Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; 86. Department of Dermatology and Allergy, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany

PDF源文件 DOI 网页
130 天

A pragmatic randomized controlled trial to improve inhaler technique using mHealth

作者Anna Vanoverschelde; Paulien van der Wel; Barbara Putman; Lies Lahousse

作者单位1. Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium; 2. Department of Medicine and Department of Environmental Medicine, New York University School of Medicine, New York, USA

PDF源文件 DOI 网页
48 天

Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes

作者Gador Bogas; Cristobalina Mayorga; Ángela Martín-Serrano; Rubén Fernández-Santamaría; Isabel M. Jiménez-Sánchez; Adriana Ariza; Esther Barrionuevo; Teresa Posadas; María Salas; Tahía Diana Fernández; María José Torres; María Isabel Montañez

作者单位1. Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Civil, Málaga, Spain; 2. Allergy Unit, Hospital Regional Universitario de Málaga, Hospital Civil, Málaga, Spain; 3. Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Parque Tecnológico de Andalucía, Málaga, Spain; 4. Departamento de Biología Celular, Genética y Fisiología, Universidad de Málaga, Málaga, Spain; 5. Departamento de Medicina, Universidad de Málaga, Facultad de Medicina, Málaga, Spain

PDF源文件 DOI 网页
13 天

Highlights and recent developments in allergic diseases in EAACI journals (2019)

作者J. Bousquet; C. E. Grattan; C. A. Akdis; P. A. Eigenmann; K. Hoffmann-Sommergruber; I. Agache; M. Jutel

作者单位1. MACVIA-France, Montpellier, France; 2. CHRU Arnaud de Villeneuve, Montpellier Cedex 5, France; 3. St John’s Institute of Dermatology, Guy’s Hospital, London, UK; 4. Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland; 5. Pediatric Allergy Unit, University Hospitals of Geneva, Geneva, Switzerland; 6. Depart of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria; 7. Transylvania University Brasov, Brasov, Romania; 8. Department of Clinical Immunology, Wrocław Medical University, Wrocław, Poland; 9. ALL-MED Medical Research Institute, Wrocław, Poland

PDF源文件 DOI 网页
43 天

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

作者Jean Bousquet; Jean-Paul Cristol; Wienczyslawa Czarlewski; Josep M. Anto; Adrian Martineau; Tari Haahtela; Susana C. Fonseca; Guido Iaccarino; Hubert Blain; Alessandro Fiocchi; G. Walter Canonica; Joao A. Fonseca; Alain Vidal; Hak-Jong Choi; Hyun Ju Kim; Vincent Le Moing; Jacques Reynes; Aziz Sheikh; Cezmi A. Akdis; Torsten Zuberbier

作者单位1. Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany; 2. University Hospital Montpellier, Montpellier, France; 3. MACVIA-France, Montpellier, France; 4. Laboratoire de Biochimie et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU, Montpellier, France; 5. Medical Consulting Czarlewski, Levallois, France; 6. MASK-Air, Montpellier, France; 7. IMIM (Hospital del Mar Research Institute), Barcelona, Spain; 8. Universitat Pompeu Fabra (UPF), Barcelona, Spain; 9. CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; 10. ISGlobAL, Barcelona, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; 11. Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; 12. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland; 13. GreenUPorto - Sustainable Agrifood Production Research Centre, DGAOT, Faculty of Sciences, University of Porto, Vila do Conde, Portugal; 14. Department of Advanced Biomedical Sciences, Federico II University, Napoli, Italy; 15. Department of Geriatrics, Montpellier University Hospital, Montpellier, France; 16. Division of Allergy, Department of Pediatric Medicine, The Bambino Gesu Children’s Research Hospital Holy See, Rome, Italy; 17. Personalized Medicine Asthma and Allergy Clinic-Humanitas University & Research Hospital, IRCCS, Milano, Italy; 18. CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto; and Medida,, Porto, Portugal; 19. World Business Council for Sustainable Development (WBCSD) Maison de la Paix, Geneva, Switzerland; 20. AgroParisTech-Paris Institute of Technology for Life, Food and Environmental Sciences, Paris, France; 21. Microbiology and Functionality Research Group, Research and Development Division, World Institute of Kimchi, Gwangju, Korea; 22. SME Service Department, Strategy and Planning Division, World Institute of Kimchi, Gwangju, Korea; 23. Maladies Infectieuses et Tropicales, CHU, Montpellier, France; 24. The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK; 25. Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland

PDF源文件 DOI 网页
70 天

IgE-binding to vicilin-like antimicrobial peptides is associated with systemic reactions to macadamia nut

作者Anna M. Ehlers; Stefanie Rohwer; Henny G. Otten; Bettina Brix; Thuy-My Le; Waltraud Suer; André C. Knulst

作者单位1. Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; 2. Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; 3. Euroimmun AG, Lübeck, Germany

PDF源文件 DOI 网页
205 天

Hereditary angioedema caused by a premature stop codon mutation in the SERPING1 gene

作者Ying-Yang Xu; Jian-Qing Gu; Yu-Xiang Zhi

作者单位1. Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。